COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Ring Therapeutics develops anellovirus-based Anellogy platform that engineers Anellovectors—non-integrating circular single-stranded DNA vectors with tissue-specific tropism, multi-route delivery, and potential repeat dosing for gene and nucleic acid therapies.
